|
Status |
Public on Oct 01, 2019 |
Title |
T,biological rep2 |
Sample type |
RNA |
|
|
Source name |
bladder cancer T24 cells treated with piperlongumine
|
Organism |
Homo sapiens |
Characteristics |
cell line: T24 cell type: bladder cancer cell line treated with: Piperlongumine (PL)
|
Treatment protocol |
T24 cells was subsequently treated with PL 20 μM or 0 μM (DMSO control)
|
Growth protocol |
T24 cells in logarithmic growth phase were seeded in 60 mm dishes at a density of 4 × 104 cell/cm2 and incubated overnight.
|
Extracted molecule |
total RNA |
Extraction protocol |
After drug treatment, total RNA was extracted from bladder cancer cell using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol.
|
Label |
biotin
|
Label protocol |
1000 ng of total RNA was labeled using Affymetrix Flashtag Biotin HSR RNA Labeling kit (P/N 901910, Affymetrix, Santa Clara, CA, USA) according to the manufacturer's instructions.
|
|
|
Hybridization protocol |
900 ng of biotin labeled RNA was hybridized to Affymetrix GeneChip® miRNA 4.0 Arrays at 48 °C and 60 rpm for 16-18 h.
|
Scan protocol |
GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.
|
Description |
A1089 miRNA expression data from piperlongumine treated bladder cancer T24 cells
|
Data processing |
Data were collected using Affymetrix Command Console Software.
|
|
|
Submission date |
Oct 08, 2017 |
Last update date |
Oct 01, 2019 |
Contact name |
Di Liu |
E-mail(s) |
[email protected]
|
Phone |
13507171375
|
Organization name |
Union Hospital
|
Department |
Department of Urology
|
Street address |
1277 Jiefang Road
|
City |
Wuhan |
State/province |
Hubei |
ZIP/Postal code |
430022 |
Country |
China |
|
|
Platform ID |
GPL21572 |
Series (1) |
GSE104717 |
Expression data from piperlongumine treated bladder cancer T24 cells |
|